Neurological Disorder Prevalence Fuels Growth Of The Induced Pluripotent Stem Cell Market Is Affecting The Direction Of The Induced Pluripotent Stem Cell (iPSC) Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Value Outlook For The Induced Pluripotent Stem Cell (iPSC) Market Through 2030?
The market size for induced pluripotent stem cells (iPSC) has seen robust growth in recent years. It is projected to expand from $3.67 billion in 2025 to $4.02 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. This historical expansion is attributable to advancements in cellular reprogramming research, ethical considerations surrounding embryonic stem cells, increased investment in stem cell research, the rise of academic research collaborations, and the growing prevalence of chronic and degenerative diseases.
The induced pluripotent stem cell (iPSC) market is projected for significant expansion in the coming years. This market is anticipated to reach $5.75 billion by 2030, showing a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this projected growth include the expanding applications of regenerative medicine, a heightened demand for personalized therapies, increased investment in cell and gene therapy, the growing use of iPSCs in neurological and cardiac research, and supportive regulatory environments for advanced therapies. Key trends during this period are expected to involve the increased application of iPSCs in disease modeling, wider adoption in drug discovery and toxicity testing, the development of more patient-specific cell lines, a growing emphasis on ethical alternatives to embryonic stem cells, and improvements in reprogramming efficiency and cell stability.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp
What Influential Factors Are Boosting The Induced Pluripotent Stem Cell (iPSC) Market Demand?
The escalating occurrence of neurological disorders is anticipated to stimulate the expansion of the induced pluripotent stem cell market in the foreseeable future. A neurological disorder describes a health condition affecting the nervous system, which includes the brain, spinal cord, and nerves. Common examples of these disorders encompass acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells present avenues for researching disease mechanisms and conducting drug tests, offering valuable understanding into the origins of neurological disorders and assisting in the creation of regenerative therapies for conditions such as Parkinson’s and Alzheimer’s disease. For illustration, in October 2023, information from the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, revealed that over 40% of the global population was afflicted by a neurological condition, and the overall neurological disease burden was projected to nearly double by 2050. Thus, the rising incidence of neurological disorders is propelling the growth of the induced pluripotent stem cell market.
What Key Segment Areas Are Included In The Induced Pluripotent Stem Cell (iPSC) Market Assessment?
The induced pluripotent stem cell (ipsc) market covered in this report is segmented –
1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types
2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy
3) By End-User: Hospitals, Research Laboratories
Subsegments:
1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies
2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research
3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies
4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications
5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research
Which Trends Are Expected To Shape The Induced Pluripotent Stem Cell (iPSC) Market?
Key enterprises within the induced pluripotent stem cell (IPSC) market are forming partnerships to propel iPSC Technology forward, with their collective aim being to bolster applications in regenerative medicine, refine disease modeling techniques, expedite drug discovery efforts, and create customized therapeutic options. Induced Pluripotent Stem Cell (iPSC) technology describes the scientific procedures and methods employed to revert adult somatic cells (like skin or blood cells) into a pluripotent state, enabling these cells to then differentiate into any type of cell within the body. Illustrating this trend, in April 2024, SCG Cell Therapy Pte Ltd, a biotechnology firm from Singapore, along with the Agency for Science, Technology and Research, a statutory board also based in Singapore, inaugurated shared laboratories dedicated to advancing cellular immunotherapies. Financial backing for this endeavor totals nearly S$30 million, highlighting Singapore’s dedication to fostering advancements in both biotechnology and healthcare solutions. The primary goal of this partnership is to establish manufacturing processes for GMP-grade iPSC products that can be scaled up, directly addressing the difficulties in moving laboratory discoveries into therapies that can be used clinically.
Who Are The Firms Contributing To The Induced Pluripotent Stem Cell (iPSC) Market Ecosystem?
Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart
Access The Complete Induced Pluripotent Stem Cell (iPSC) Market Report:
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report
Which Region Leads The Induced Pluripotent Stem Cell (iPSC) Market By Size?
North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Induced Pluripotent Stem Cell (iPSC) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp
Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company
Noise Mitigation System Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/noise-mitigation-system-global-market-report
Automotive Noise Insulation Parts Global Market Report 2026
Architectural Acoustic Panels Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/architectural-acoustic-panels-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
